Anthony Epstein

Q: What Schools Are Affiliated With Anthony Epstein

Anthony Epstein is affiliated with the following schools: University of Bristol, University of Pennsylvania

Anthony Epstein's AcademicInfluence.com Rankings

Anthony Epstein

Biology

#907

World Rank

#1589

Historical Rank

Virology

#50

World Rank

#52

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Anthony Epstein Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Michael Anthony Epstein is a British pathologist and academic. He is one of the discoverers of the Epstein–Barr virus, along with Yvonne Barr and Bert Achong. Early and personal life Epstein was born on 18 May 1921, and educated at St Paul's School in London, Trinity College, Cambridge, and Middlesex Hospital Medical School.

(See a Problem?)

Anthony Epstein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. (1964) (2493)
The Epstein-Barr Virus (1979) (435)
Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). (1966) (413)
A re‐examination of the epstein‐barr virus carrier state in healthy seropositive individuals (1985) (339)
MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA (1965) (317)
CULTIVATION IN VITRO OF HUMAN LYMPHOBLASTS FROM BURKITT'S MALIGNANT LYMPHOMA. (1964) (294)
PREINVASIVE CANCER OF THE CERVIX. (1964) (293)
An unusual virus in cultures from a human nasopharyngeal carcinoma. (1971) (246)
Long-term T-cell-mediated immunity to Epstein-Barr virus. (1981) (220)
DESFERRIOXAMINE AND IRON. (1964) (206)
Protection of cottontop tamarins against Epstein–Barr virus-induced malignant lymphoma by a prototype subunit vaccine (1985) (192)
The Epstein-Barr virus : recent advances (1986) (157)
Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs (1980) (144)
Monoclonal antibodies to epstein‐barr virus‐induced, transformation‐associated cell surface antigens: Binding patterns and effect upon virus‐specific t‐cell cytotoxicity (1982) (138)
HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells (1980) (136)
Pilot experiments with EB virus in owl monkeys (aotus trivirgatus). I. Reticuloproliferative disease in an inoculated animal (1973) (136)
T-cell-mediated regression of "spontaneous" and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. (1984) (130)
DEATHS IN THE COMMUNITY. (1964) (130)
OBSERVATIONS ON THE MODE OF RELEASE OF HERPES VIRUS FROM INFECTED HELA CELLS (1962) (128)
CHARACTERISTICS AND MODE OF GROWTH OF TISSUE CULTURE STRAIN (EB1) OF HUMAN LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. (1965) (123)
The Relationship of the Virus to Burkitt’s Lymphoma (1979) (120)
Cytogenetic studies on human lymphoblastoid cell lines from burkitt's lymphomas and other sources (1974) (117)
Distinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma (1985) (110)
Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B-cell clones. (1985) (106)
Epstein–Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen (1982) (102)
FINE STRUCTURAL ORGANIZATION OF HUMAN LYMPHOBLASTS OF A TISSUE CULTURE STRAIN (EB1) FROM BURKIT'S LYMPHOMA. (1965) (101)
Recombinant vaccinia virus expressing epstein‐barr virus glycoprotein gp340 protects cottontop tamarins against EB virus‐induced malignant lymphomas (1988) (100)
SOME UNUSUAL FEATURES OF FINE STRUCTURE OBSERVED IN HELA CELLS (1961) (99)
Recent progress in Epstein-Barr virus research. (1977) (95)
The EB virus. (1973) (91)
Studies with Burkitt's lymphoma. (1965) (90)
Observations on the type of infection by epstein‐barr virus in peripheral lymphoid cells of patients with infectious mononucleosis (1974) (89)
Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro (1981) (88)
THE LOCALIZATION BY ELECTRON MICROSCOPY OF HELA CELL SURFACE ENZYMES SPLITTING ADENOSINE TRIPHOSPHATE (1963) (84)
PATHOGENESIS OF INFECTIOUS MONONUCLEOSIS (1977) (82)
In vitro analysis of the epstein‐barr virus: Host balance in long‐term renal allograft recipients (1985) (80)
International Review of Experimental Pathology (1986) (78)
Various forms of Epstein-Barr virus infection in man: established facts and a general concept. (1973) (77)
Isolation of infectious EB virus from the epithelial tumour cells of nasopharyngeal carcinoma (1977) (76)
THE FINE STRUCTURE OF THE CELLS IN MOUSE SARCOMA 37 ASCITIC FLUIDS (1957) (76)
Reactivation of epstein‐barr virus‐specific cytotoxic t cells by in vitro stimulation with the autologous lymphoblastoid cell line (1981) (75)
OBSERVATIONS ON THE FINE STRUCTURE OF MATURE HERPES SIMPLEX VIRUS AND ON THE COMPOSITION OF ITS NUCLEOID (1962) (72)
Validation of a first‐generation epstein‐barr virus vaccine preparation suitable for human use (1989) (71)
Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas (1979) (69)
THE FINE STRUCTURAL ORGANISATION OF ROUS TUMOUR CELLS (1957) (67)
Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients. (1977) (67)
Fine Structure of the Burkitt Tumor (1966) (66)
The Behaviour and Morphology of a Second Tissue Culture Strain (EB2) of Lymphoblasts from Burkitt's Lymphoma (1965) (64)
Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. I. Virus-specific and nonspecific components of the cytotoxic response. (1982) (61)
Factors influencing population growth of a colony of cotton-top tamarins (1983) (61)
Sequential appearance of Epstein–Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation (1981) (61)
A SECOND VIRUS-CARRYING TISSUE CULTURE STRAIN (EB2) OF LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. (1964) (61)
Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants (1981) (60)
Observations on the EB virus envelope and virus‐determined membrane antigen (MA) polypeptides (1980) (60)
Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells. (1982) (60)
Specific immunofluorescence test for the herpes-type EB virus of Burkitt lymphoblasts, authenticated by electron microscopy. (1968) (59)
Introduction: Discovery and General Biology of the Virus (1979) (59)
Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. III. Establishment of HLA‐restricted cytotoxic T cell lines using interleukin 2 (1982) (58)
Pilot experiments with EB virus in owl monkeys (aotus trivirgatus). II. EB virus in a cell line from an animal with reticuloproliferative disease (1973) (57)
Comparative studies on adult donor lymphocytes infected by EB virus in vivo or in vitro: Origin of transformed cells arising in co‐cultures with foetal lymphocytes (1977) (57)
Not all potently neutralizing, vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals. (1986) (56)
Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes. (1982) (53)
Control of Cellular Growth in Adult Organisms. (1968) (53)
Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants (1983) (53)
Structure and Development of the Herpes-Type Virus of Marek's Disease (1968) (52)
EPSTEIN-BARR-VIRUS-SPECIFIC T-CELL MEMORY IN RENAL-ALLOGRAFT RECIPIENTS UNDER LONG-TERM IMMUNOSUPPRESSION (1982) (51)
Activation in vitro by BUdR of a productive eb virus infection in the epithelial cells of nasopharyngeal carcinoma (1976) (50)
THE ENTRY AND DISTRIBUTION OF HERPES VIRUS AND COLLOIDAL GOLD IN HELA CELLS AFTER CONTACT IN SUSPENSION (1964) (49)
Paired epstein‐barr virus‐carrying lymphoma and lymphoblastoid cell lines Burkitt's lymphoma patients: Comparative sensitivity to non‐specific and to allo‐specific cytotoxic responses in vitro (1984) (48)
The prevalence of naturally occurring antibodies to human syncytial virus in East African populations. (1980) (48)
Burkitt lymphoma in New Guinea: establishment of a line of lymphoblasts in vitro and description of their fine structure. (1967) (47)
Aspects of the EB virus. (1970) (43)
Virus in cultured lymphoblasts from a New Guinea Burkitt lymphoma. (1967) (43)
Absence of infectious Epstein–Barr virus in blood in acute infectious mononucleosis (1975) (42)
A structural investigation of the Epstein-Barr (EB) virus membrane antigen glycoprotein, gp340. (1984) (42)
Therapeutic factors in survival after lethal cholinesterase inhibition by phosphorus insecticides. (1955) (41)
Observations on the Rous Virus; Integrated Electron Microscopical and Cytochemical Studies of Fluorocarbon Purified Preparations (1958) (40)
Cultivation and fine structure of virus‐bearing lymphoblasts from a second new guinea burkitt lymphoma: Establishment of sublines with unusual cultural properties (1968) (40)
Virological and immunological studies on a fatal case of infectious mononucleosis (1979) (39)
Comparative immunogenicity studies on epstein‐barr virus membrane antigen (MA) gp340 with novel adjuvants in mice, rabbits, and cotton‐top tamarins (1984) (39)
Studies on a group of oximes as therapeutic compounds in sarin poisoning. (1957) (38)
Preliminary observations on new lymphoblast strains (EB4, EB5) from Burkitt tumours in a British and a Ugandan patient. (1966) (38)
Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen (1983) (37)
Pilot experiments with eb virus in owl monkeys (aotus trivirgatus). III. Serological and biochemical findings in an animal with reticuloproliferative disease (1975) (36)
Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis. (1978) (35)
Interaction of Epstein‐Barr virus with leukaemic B cells in vitro. II. Cell line establishment from prolymphocytic leukaemia and from Waldenström's macroglobulinaemia (1982) (33)
Disturbance of the Epstein-Barr virus-host balance in rheumatoid arthritis patients: a quantitative study. (1986) (33)
Purification and properties of the gp340 component of Epstein-Barr virus membrane antigen in an immunogenic form. (1983) (33)
Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine. (1983) (33)
Mechanism of the establishment of epstein‐barr virus genome‐containing lymphoid cell lines from infectious mononucleosis patients: Studies with phosphonoacetate (1977) (32)
Preliminary seroepidemiological studies on the human syncytial virus. (1978) (32)
ELECTRON MICROSCOPE OBSERVATIONS ON THE SURFACE ADENOSINE TRIPHOSPHATASE-LIKE ENZYMES OF HELA CELLS INFECTED WITH HERPES VIRUS (1963) (31)
Further observations on a human syncytial virus from a nasopharyngeal carcinoma. (1974) (31)
AN INTERESTING CASE IN WARD 6. (1964) (29)
A highly sensitive enzyme-linked immunosorbent assay to quantitate antibodies to Epstein-Barr virus membrane antigen gp340. (1984) (29)
Rearing a second generation of cotton-top tamarins (Saguinus oedipus oedipus) in captivity (1985) (28)
Reflections on Epstein-Barr virus: some recently resolved old uncertainties. (2001) (28)
VACCINATION AGAINST EPSTEIN-BARR VIRUS: CURRENT PROGRESS AND FUTURE STRATEGIES (1986) (26)
Observations on the nature of the herpes-type EB virus in cultured Burkitt lymphoblasts, using a specific immunofluorescence test. (1968) (26)
Further biological properties of the human syncytial virus. (1977) (25)
Epstein-Barr virus--is it time to develop a vaccine program? (1976) (25)
Sensitivity of the transforming and replicative functions of Epstein--Barr virus to inhibition by phosphonoacetate. (1978) (24)
Quantification of an Epstein-Barr virus-associated membrane antigen component. (1982) (24)
IARC Scientific Publications No. 11. Oncogenesis and herpesviruses II. 2. Epidemiology, host response and control. (1975) (23)
Why and How Epstein-Barr Virus Was Discovered 50 Years Ago. (2015) (23)
Oropharyngeal shedding of infectious Epstein-Barr virus in healthy virus-immune donors. A prospective study. (1985) (22)
A new human virus in cultures from a nasopharyngeal carcinoma. (1971) (22)
Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma. (1985) (22)
The Leeuwenhoek Lecture, 1983 A prototype vaccine to prevent Epstein-Barr virus-associated tumours (1984) (21)
An investigation into the purifying effect of a fluorocarbon on vaccinia virus. (1958) (21)
Burkitt lymphoma and the discovery of Epstein–Barr virus (2012) (21)
Implications of a vaccine for the prevention of Epstein-Barr virus infection: ethical and logistic considerations. (1976) (20)
Observations on the Fine Structure of Type 5 Adenovirus (1959) (20)
Composition of the Rous Virus Nucleoid (1958) (20)
Adenocarcinoma of the large bowel and colitis in captive cotton-top tamarins Saguinus o. oedipus. (1986) (19)
Naturally occurring antibodies to the human syncytial virus in west africa (1983) (19)
Morphological observations on the replication of herpesvirus saimiri in monkey kidney cell cultures. (1976) (18)
Morphological Confirmation of the Herpes Nature of a Carcinogenic Virus of Primates (Herpes saimiri) (1970) (18)
Identification of murine endogenous xenotropic retrovirus in cultured multicellular tumour spheroids from nude‐mouse‐passaged nasopharyngeal carcinoma (1979) (18)
SUBMICROSCOPIC ORTHO- AND PATHO-MORPHOLOGY OF THE LIVER (1965) (17)
Unusual Intranuclear Tubular Structures Associated with the Maturation of Herpesvirus saimiri in Monkey Kidney Cell Cultures (1973) (17)
The abnormal cytotoxic T cell response to Epstein-Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies. (1986) (17)
Burkitt's lymphoma: Clues to the role of malaria (1984) (16)
Cytogenetics of malignant epithelial cells and lymphoblastoid cell lines from nasopharyngeal carcinoma. (1978) (16)
THERAPEUTIC USE OF HUMAN MONOCLONAL ANTIBODIES (1983) (15)
The fine structure and composition of type 5 adenovirus; an integrated electron microscopical and cytochemical study. (1960) (15)
Epstein-Barr virus as the cause of a human cancer (1978) (15)
Vaccination Against Epstein-Barr Virus (1991) (14)
Direct membrane fluorescence reaction of EBV‐carrying human lymphoblastoid cells: Blocking tests with xenogeneic antisera (1969) (14)
Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. II. Cytotoxic response to repeated stimulation. (1982) (13)
Morphology of the Virus and of Virus-Induced Cytopathologic Changes (1979) (13)
A METHOD FOR PREPARING MICROSAMPLES OF SUSPENDED CELLS FOR LIGHT AND ELECTRON MICROSCOPY. (1965) (11)
Adenosine Triphosphatase Activity at the Surface of Mature Extracellular Herpes Virus (1963) (11)
The isolation of type 5 adenovirus using a fluorocarbon; combined morphological and biological studies. (1960) (10)
Formal discussion: immunologic relationships of the herpes-like EB virus of cultured Burkitt lymphoblasts. (1967) (10)
Site of Virus-like Particles in Rous Fowl Sarcoma Cells (1955) (10)
Cytochemical and Electron Microscopical Observations on the Presence and Origin of Adenosine Triphosphatase-Like Activity at the Surface of Two Myxoviruses (1965) (10)
Toxicity of Hydroxamic Acid Analogues; Prophylactic and Therapeutic Efficacy Against Nerve Gas Poisoning in Mice.∗ (1956) (9)
Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients (2004) (9)
Large-scale purification of Epstein-Barr virus membrane antigen gp340 with a monoclonal antibody immunoabsorbent. (1985) (9)
The 1986 Walter Hubert lecture. Recent studies on a vaccine to prevent EB virus-associated cancers. (1986) (9)
Morphological Transformation in vitro of Human Fibroblasts by Epstein-Barr Virus: Preliminary Observations (1972) (8)
Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates. (1981) (8)
Inhibition by phosphonoacetate of the in vitro outgrowth of Epstein-Barr virus genome-containing cell lines from the blood of infectious mononucleosis patients. (1978) (8)
The role of HLA antigens in the control of the cytotoxic T-cell response to Epstein-Barr virus: a family study. (1985) (8)
Observations on the nature of Epstein-Barr virus infection of peripheral lymphoid cells in infectious mononucleosis. (1975) (8)
Epstein–Barr virus: Infection and tumour induction (1986) (7)
Production of EB virus by normal human nasopharyngeal epithelial cells exposed to the virus in vitro (1983) (7)
THE FINE STRUCTURE OF ANIMAL CELLS; A BRIEF INTRODUCTORY SURVEY1 (1959) (6)
A culture method giving substantial yields of normal nasopharyngeal epithelial cells for work with Epstein-Barr virus. (1983) (6)
Towards an anti-viral vaccine for a human cancer (1975) (6)
Cortical localization of symbolic processes in the rat: III. Impairment of anticipatory functions in prefrontal lobectomy in rats (1943) (6)
Comparisons of surface markers on Herpesvirus-associated lymphoid cells of nonhuman primates and established human lymphoid cell lines. (1975) (6)
Sequential immunofluorescence and infectivity studies on the replication of Herpesvirus saimiri in owl monkey kidney cells. (1977) (6)
Site and Nature of Adenovirus Nucleic Acid (1960) (6)
Historical background; Burkitt's lymphoma and Epstein-Barr virus. (1985) (6)
Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells (2004) (6)
Burkitt's lymphoma and Herpesvirus saimiri lymphoma: comparative aspects. (1972) (6)
Selective reactivation of Epstein-Barr virus-specific cytotoxic T cells by stimulation in vitro with allogeneic virus-transformed HLA-homozygous typing cells. (1983) (5)
Functional aspects of the structure of some animal viruses. (1962) (5)
Structural Differentiation in the Nucleoid of Mature Vaccinia Virus (1958) (4)
Gammaherpesviruses: Epstein‐Barr Virus (2010) (4)
Allospecific T cell recognition of HLA-A2 antigens: Evidence for group-specific and subgroup-specific epitopes (2004) (4)
IMMUNOLOGICAL CONTROL OF EPSTEIN‐BARR VIRUS INFECTION: POSSIBLE LESSONS FOR AIDS (1984) (4)
Vaccine Intervention Against Virus-Induced Tumours (1986) (3)
Structure and development of the herpes-types virus of Marek's disease. (1968) (3)
Oncogenic g-herpesviruses: an expanding family (2001) (3)
EB virus in the owl monkey (Aotus trivirgatus). (1976) (3)
Vaccine Control of EB Virus-Associated Tumors (1979) (3)
Pathogenesis of infectious mono-nucleosis. (1977) (3)
Recent studies with EB virus. (1975) (3)
Cytochemical and electron microscopical observations on substances associated with fluorocarbon purified vaccinia virus. (1958) (2)
Prospects of immunization against EB virus (1989) (2)
A simple technique for the electron microscopy of fresh ascites tumour cells. (1955) (2)
A technique for transferring cells prepared on Formvar coated slides to electron microscope specimen grids. (1955) (2)
Biochemistry of viral replication and in vitro transformation (1975) (2)
Constitution of tumor viruses. (1960) (2)
Epstein-Barr virus--discovery, properties and relationship to nasopharyngeal carcinoma. (1978) (2)
EPSTEIN BARR VIRUS AND NASOPHARYNGEAL CARCINOMA (1976) (2)
The Electron Microscopy of Viruses (1961) (2)
Principles and Practice of Virology (1987) (2)
Letter: Epstein-Barr virus and infectious mononucleosis. (1973) (2)
Nucleic Acid of Mature Herpes Simplex Virus : its Type and Location (1962) (2)
Endemic and sporadic cases of Epstein-Barr virus-positive Burkitt's lymphoma: immunological characterization of derived cell lines. (1985) (1)
Intra-cellular Identification of the Rous Virus (1956) (1)
The Manual of Common Communicable Diseases in Shelters (1992) (1)
Morphological transformation of human embryo fibroblasts in vitro by EB virus. (1972) (1)
Epidemiology, host response and control (1975) (1)
EPSTEIN-BARR VIRUS AND INFECTIOUS MONONUCLEOSIS (1973) (1)
Cytogenetic observations on the malignant epithelial cells and infiltrating lymphocytes of nasopharyngeal carcinoma. (1978) (1)
FUNCTIONAL FACTORS IN VIRUS STRUCTURE; A GUIDE TO GROUPING (1962) (1)
Transformation in vivo - a review. (1975) (1)
Human putative oncogenic herpesviruses. (1975) (1)
The possible significance of morphological transformation of human fibroblasts by EB virus in vitro. (1973) (1)
Proceedings: Cyotgenetic differences between burkitt lymphoma and other ebv-related human lymphoblastoid-cell lines. (1975) (1)
A prototype vaccine to prevent Epstein-Barr virus-associated cancers. (1987) (1)
Proceedings: Observations on the nature of EB-virus infection of peripheral lymphoid cells in infectious mononucleosis. (1975) (1)
Restriction of virus-specific cytotoxic T cell function by products of the major (2003) (0)
Book Review: Control of Cellular Growth in Adult Organisms (1968) (0)
In conversation Dr Denis Burkitt and Sir Anthony Epstein: Addendum (2017) (0)
The Vaccine Control of Virus-Induced Cancers (1988) (0)
Epstein-Barr Virus Infection and Cancer (1990) (0)
Book Review: The Mitochrondrion (1964) (0)
Anti-Viral Vaccine Control of EB Virus-Associated Cancers (1986) (0)
Morphological transformation of human embryo fibroblasts in vitro by EB virus. (1972) (0)
Observations on purified preparations of the Rous virus; infectivity and structure of the particles. (1959) (0)
Vaccine control of malignancies induced by lymphotropic herpesviruses. (1983) (0)
Reply (1991) (0)
Various Interviews Compilation (2017) (0)
Observations on an oncogenic herpes virus of primates. (1970) (0)
Nature and genesis of tumours (1979) (0)
Studies on the Prevention of EBV-induced Malignancies by a Sub-unit Antiviral Vaccine (1986) (0)
EPSTEIN-BARR VIRUS RESEARCH (1977) (0)
ADDICTION OF PETROL VAPOUR. (1964) (0)
Prevention of EB Virus-Associated Malignant Diseases (1985) (0)
The Medical Sciences Video-Archive of the Royal College of Physicians and Oxford Brookes University 1984- (2017) (0)
Intra-cellular identification of the Rous virus. (1956) (0)
An Aspect of Virology (1971) (0)
The electron microscopy of tissue cells; a brief review including reference to virus-infected cells. (1955) (0)
The Structure and Function of Animal Cell Components: An Introductory Text (2013) (0)
A Subunit Vaccine against Epstein-Barr Virus (1985) (0)
Cytogenic differences between Burkitt's lymphoma and other EBV-related human lymphoblastoid cell lines. (1975) (0)
Book Review: Cellular Injury (1965) (0)
Prevention of endemic Burkitt's lymphoma. (1985) (0)
This Week's Citation Classic (1978) (0)
The first real human type-C retrovirus. (1982) (0)
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 356 (1408) (2001) (0)
Theabnormal cytotoxic Tcell responsetoEpstein- Barrvirus inrheumatoid arthritis iscorrelated with disease activity andoccursinother arthropathies (1986) (0)
Plans for Human Trials of a Vaccine Against Epstein-Barr Virus Infection (1991) (0)
Recent studies with EB virus. 1975. (2000) (0)
Cytochemical andElectron Microscopical Observa- tions on thePresence andOrigin ofAdenosine Triphosphatase-Like Activity atthe Surface ofTwoMyxoviruses (1965) (0)
Recent Progress with Vaccines Against Epstein-Barr Virus Infection (1989) (0)
This disease of mine (1982) (0)
Title Page / Table of Contents / Abstracts (1988) (0)
International Symposium on Hodgkin's Disease. Session 1. Epidemiology and etiology. Part 2. Virology and serology--new approaches to identification of an etiologic agent. (1973) (0)

This paper list is powered by the following services:

Other Resources About Anthony Epstein

en.wikipedia.org

What Schools Are Affiliated With Anthony Epstein?

Anthony Epstein is affiliated with the following schools: